Human umbilical cord mesenchymal stem cells inhibit C6 glioma growth via secretion of dickkopf-1 (DKK1). (Q39084489)

8 September 2017

Human umbilical cord mesenchymal stem cells inhibit C6 glioma growth via secretion of dickkopf-1 (DKK1). (English)

1 reference

human umbilical cord mesenchymal stem cell

8 September 2017

1 reference

Shanshan Ma

1

1 reference

8 September 2017

Shuo Liang

2

1 reference

8 September 2017

Hongliang Jiao

3

1 reference

8 September 2017

Liankai Chi

4

1 reference

8 September 2017

Xinyi Shi

5

1 reference

8 September 2017

Yi Tian

6

1 reference

8 September 2017

Bo Yang

7

1 reference

8 September 2017

Fangxia Guan

8

1 reference

8 September 2017

9 October 2013

1 reference

Molecular and Cellular Biochemistry

8 September 2017

1 reference

8 September 2017

385

1 reference

8 September 2017

1-2

1 reference

8 September 2017

277-286

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1836-y

8 September 2017

0 references

cites work

Clinical and radiological prognostic factors of anaplastic oligodendroglioma treated by combined therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Search and destroy: recent research exploits adult stem cells' attraction to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

21 January 2018

Regenerating the heart

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Human amniotic membrane derived-mesenchymal stem cells induce C6 glioma apoptosis in vivo through the Bcl-2/caspase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Wnt/beta-catenin signaling in cancer stemness and malignant behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1836-Y

Prostate cancer cells promote osteoblastic bone metastases through Wnts

21 January 2018

1 reference

12 December 2020

The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells

1 reference

12 December 2020

Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.

1 reference

12 December 2020

Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents

1 reference

12 December 2020

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

1 reference

12 December 2020

10.1007/S11010-013-1836-Y

Identifiers

DOI

1 reference

8 September 2017

1 reference